US11325839B2ActiveUtilityA1

Zinc oxide particle preparation and methods of use

Assignee: UNIV IMAM ABDULRAHMAN BIN FAISALPriority: Jan 11, 2018Filed: Jan 11, 2018Granted: May 10, 2022
Est. expiryJan 11, 2038(~11.5 yrs left)· nominal 20-yr term from priority
B01J 2235/00B01J 2235/30B01J 2235/15B01J 35/70B01J 35/51A61K 9/14C02F 1/725A23K 50/40B01J 37/009A23K 50/10C02F 1/281C01P 2002/84C01P 2006/16B01J 37/031A23K 50/20C01P 2004/61B01J 23/06C01P 2006/12A61P 35/00C01P 2006/14C01G 9/02C02F 1/00A23L 33/16C01P 2004/30C01P 2004/03B01J 20/28019A23K 20/30B01J 20/28007C02F 1/32B01J 20/28059C01P 2002/72C02F 2101/308C02F 2305/10A23K 50/50B01J 20/06C01P 2004/62C01P 2004/32A23V 2002/00A61K 33/30C02F 1/30B01J 35/002B01J 35/1014B01J 35/08B01J 35/1038B01J 35/1061B01J 35/004B01J 35/1009B01J 35/0013B01J 35/39B01J 35/612B01J 35/613B01J 35/633B01J 35/647
65
PatentIndex Score
0
Cited by
18
References
6
Claims

Abstract

A method of using ZnO particles for the treatment of colon cancer and a method of using the particles for reducing the concentration of an organic contaminant in an aqueous solution is described. The ZnO particles are substantially spherical and may have nanopetals that provide a nanoflower morphology. The synthesis and characterization of the ZnO particles is also discussed.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for treating colon cancer cells in vitro, comprising:
 first forming ZnO particles by mixing zinc nitrate and sodium hydroxide in water and refluxing at 80° C., then cooling to form a precipitate and washing the precipitate to obtain the ZnO particles, then 
 contacting the ZnO particles with the colon cancer cells in a cytotoxicity effective dose, wherein the ZnO particles have substantially spherical shapes with diameters of 1.5-3.5 μm and BET surface areas of 15-25 m 2 /g, wherein the colon cancer cells are contacted with the ZnO particles at a concentration of 0.2-1 mg/mL to suppress the growth of the colon cancer cells by 56.62-72.86%, 
 wherein a surface of the ZnO particles has nanopetals of 50-200 nm thickness extending 100-500 nm from the surface, the nanopetals traversing the surface with lengths of 500 nm-2 μm, and 
 wherein the ZnO particles are porous with pore sizes of 20-35 nm. 
 
     
     
       2. The method of  claim 1 , wherein the ZnO particles are contacted with the colon cancer cells as a part of a composition, wherein the composition further comprises a food product, a pharmaceutically acceptable excipient, a pharmaceutically acceptable carrier, or an antioxidant. 
     
     
       3. The method of  claim 1 , wherein the ZnO particles consist essentially of ZnO. 
     
     
       4. The method of  claim 1 , wherein the nanopetals have a thickness of 85-120 nm and extend 180-350 nm from the surface, and
 wherein the nanopetals traverse the surface with lengths of 900 nm-1.2 μm, and 
 wherein 80-99% of the surface is covered with the nanopetals. 
 
     
     
       5. The method of  claim 1 , wherein the ZnO particles are monodisperse with a coefficient of variation of less than 10%. 
     
     
       6. The method of  claim 1 , wherein the ZnO particles have pore volumes of 0.10-0.15 cm 3 /g.

Join the waitlist — get patent alerts

Track US11325839B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.